Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
4(36%)
Results Posted
40%(2 trials)
Terminated
1(9%)

Phase Distribution

Ph not_applicable
3
27%
Ph early_phase_1
2
18%
Ph phase_1
3
27%
Ph phase_2
1
9%

Phase Distribution

5

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
2(22.2%)
Phase 1Safety & dosage
3(33.3%)
Phase 2Efficacy & side effects
1(11.1%)
N/ANon-phased studies
3(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

4

trials recruiting

Total Trials

11

all time

Status Distribution
Active(4)
Completed(5)
Terminated(2)

Detailed Status

Completed5
Recruiting3
Active, not recruiting1
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
4
Success Rate
83.3%
Most Advanced
Phase 2

Trials by Phase

Early Phase 12 (22.2%)
Phase 13 (33.3%)
Phase 21 (11.1%)
N/A3 (33.3%)

Trials by Status

recruiting327%
active_not_recruiting19%
terminated19%
completed545%
withdrawn19%

Recent Activity

4 active trials
Showing 5 of 11
recruiting

Quantitative MRI Assessment of Breast Cancer Therapy Response

NCT05704062
recruitingphase_1

PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT02390635
active_not_recruitingphase_1

Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma

NCT02359565
recruitingnot_applicable

An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response

NCT04796818
completedphase_2

18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy

NCT01991977
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT05704062

Quantitative MRI Assessment of Breast Cancer Therapy Response

Recruiting
NCT02390635Phase 1

PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia

Recruiting
NCT02359565Phase 1

Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma

Active Not Recruiting
NCT04796818Not Applicable

An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response

Recruiting
NCT01991977Phase 2

18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy

Completed
NCT02020720Early Phase 1

18F-DOPA-PET in Planning Surgery in Patients With Gliomas

Completed
NCT06090630Early Phase 1

MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer

Completed
NCT01992861

MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer

Terminated
NCT00662506Phase 1

Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Completed
NCT02590497Not Applicable

Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery

Withdrawn
NCT00660543Not Applicable

MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy

Completed

All 11 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
11